FATE insider buying
FATE THERAPEUTICS INC
Every qualifying open-market purchase of FATE reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in FATE yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in FATE
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Dec 20, 2024 | Director, 10% Owner | 397,964 | $1.68 | $668.6K | SEC ↗ |
FATE insider buying — FAQ
- Are insiders buying FATE stock?
- 1 insider has bought FATE (FATE THERAPEUTICS INC) on the open market, most recently on Dec 26, 2024. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much FATE stock have insiders bought?
- Insiders have bought a combined $668.6K of FATE across 1 open-market purchase, based on SEC Form 4 filings.
- What is an insider cluster buy in FATE?
- A cluster buy is two or more distinct FATE THERAPEUTICS INC insiders — officers, directors, or 10% owners — each buying FATE on the open market within a rolling window. None has been detected in FATE yet.
- Where does this FATE insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in FATE
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy FATE within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding FATE.